X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Experimental and Therapeutic Medicine

期刊標題檢索 EXP THER MED 最新評論: Overall, the magazine is quite professional, with editors reviewing an... (2024-05-07)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Experimental and Therapeutic Medicine]您好,您是該頁面的第 230761 位訪客。

期刊簡介
期刊名稱Experimental and Therapeutic Medicine Experimental and Therapeutic Medicine
LetPub Score
4.3
50 ratings
Rate

Reputation
3.2

Influence
4.2

Speed
8.5

期刊簡稱EXP THER MED
ISSN1792-0981
h-index33
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.500.0000.000
Subject fieldQuartilesRankPercentile
Category: Immunology and Microbiology
Subcategory: Immunology and Microbiology (miscellaneous)
Q3 / 4
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q148 / 191

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
官方網站https://www.spandidos-publications.com/etm/
在線稿件提交https://www.spandidos-publications.com/login
開放訪問No
出版商SPANDIDOS PUBL LTD
主題領域MEDICINE, RESEARCH & EXPERIMENTAL
出版國/地區GREECE
發行頻率
創刊年2010
每年文章數562每年文章數趨勢
黃金OA百分比99.56%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3105/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1792-0981%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.3 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【Experimental and Therapeutic Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE644480
    BIOMATERIALS595468
    Frontiers in Pharmacology499450
    BIOMEDICINE & PHARMACOTHERAPY498563
    JOURNAL OF ETHNOPHARMACOLOGY488999
    Journal of Materials Chemistry B476135
    Frontiers in Immunology460718
    COLLOIDS AND SURFACES B-BIOINTERFACES419440
    COMPUTERS IN BIOLOGY AND MEDICINE418729
    Frontiers in Oncology415245
  •  

    Experimental and Therapeutic Medicine Experimental and Therapeutic Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/41)
  [Experimental and Therapeutic Medicine] 的評論撰寫評論
作者: 白云爱成


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-07 19:54:54 評論於
Overall, the magazine is quite professional, with editors reviewing and editing the articles multiple times to improve their quality. However, the review process can be quite lengthy, taking around 5 months for the first review. If you are not in a hurry, you can submit your work
(0) 讚! | 白云爱成

作者: scut@Alexander


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-11 14:40:03 評論於
How much is the layout fee for this magazine?
(0) 讚! | scut@Alexander

作者: Ziyang666


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 10:50:30 評論於
This journal requests 5 recommended reviewers. Will they choose the reviewers I recommend, or will the system allocate them on its own?
(0) 讚! | Ziyang666

作者: 温斯顿弗朗西斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-22 13:41:04 評論於
I suggest to withdraw the submission for editing, I have already revised it. Damn, it's really frustrating
(0) 讚! | 温斯顿弗朗西斯

作者: 日光半菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-17 23:55:41 評論於
Warning, what should we do?
(0) 讚! | 日光半菡

作者: xx


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-01 21:13:56 評論於
It's too slow, it's been half a month and there's still no news
(0) 讚! | xx

作者: 气甲胜换


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-25 21:33:22 評論於
Oh, really? I thought you accepted it
(0) 讚! | 气甲胜换

作者: 苍风悦宜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 23:28:08 評論於
Research focus: Sharing of basic research experience: Particularly bad, after receiving it, it was repeatedly revised according to the requirements of the journal, and it has been in production for a long time. Really urgent, so I sent an email to inquire, only to receive a rejection email. It's really disappointing. To be honest, even a journal with ranking of level 4 also affects oneself, but don't waste time on such journals
(0) 讚! | 苍风悦宜

作者: 月河啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-22 13:10:48 評論於
Do reviewers request raw data for all experiments including PCR?
(0) 讚! | 月河啸天

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 18:02:10 評論於
Bank remittance can be traced currently
(0) 讚! | 京城芳洲

作者: 韶容三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-22 22:06:55 評論於
How much is the layout fee?
(0) 讚! | 韶容三岁啦

作者: 东京乙巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-21 17:08:57 評論於
How did you pay the page fee? Can it be searched on WOS?
(0) 讚! | 东京乙巳

作者: 南川云娴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-14 10:48:55 評論於
Receive your lucky blessing
(0) 讚! | 南川云娴

作者: 南川云娴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 20:47:46 評論於
Was the rejection because the similarity rate was too high after receiving?
(0) 讚! | 南川云娴

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 18:13:05 評論於
Please translate the following passage into English and Japanese, and label them as ":" and ":"
(0) 讚! | 京城芳洲

作者: 绿旋来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-08 21:54:14 評論於
Are you using the first payment method or the second payment method?
(0) 讚! | 绿旋来了

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-01 19:08:41 評論於
Currently cannot be indexed
(0) 讚! | 京城芳洲

作者: 绿旋来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-29 19:26:32 評論於
Received online, how long?
(0) 讚! | 绿旋来了

作者: freefate


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-28 09:05:48 評論於
Either reject or accept, I have to do it
(0) 讚! | freefate

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-25 18:00:55 評論於
I have also been proofread by other companies and have already accepted it. It should not affect
(0) 讚! | 京城芳洲

作者: 筑阳云水


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-23 14:30:42 評論於
After reading the comments, I realized that my revisions were done by another company. Am I doomed to fail already? Just waiting to be rejected
(0) 讚! | 筑阳云水

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 12:09:00 評論於
The external audit took one month and 11 days, which is still considered quite fast
(0) 讚! | 京城芳洲

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-29 15:44:45 評論於
Submitted on 07.10, under review on 07.12, minor revisions on 8.23, accepted on 9.04, with 4 rounds of proofreading in between. Paid page charges on 10.07, waiting for online publication. Although it is considered a low-impact journal, it is a meta-analysis, so I am already satisfied with being able to publish it
(0) 讚! | 京城芳洲

作者: 是你的乐逸呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-26 22:39:03 評論於
Has your article been accepted? It has been three months since I submitted mine. I asked for an update once, and was informed that the external review time is uncertain. Will the magazine accept it? I am in a hurry to graduate
(0) 讚! | 是你的乐逸呀

作者: 是你的乐逸呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-25 23:00:48 評論於
May I ask how your article is going? My submission has been under review since March and is still in the external review process
(0) 讚! | 是你的乐逸呀

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/41)

開始撰寫 [Experimental and Therapeutic Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*